Hemogenyx Pharmaceuticals PLC Announces Lentivirus Re-manufacturing Completed

Hemogenyx Pharmaceuticals plc is pleased to announce the successful completion of the re-manufacturing of an improved lentivirus devoid of splice variants.

Scroll to Top